Australian Shares – Resmed (RMD)
Resmed (RMD) is a healthcare business, manufacturing medical products for the treatment of respiratory and sleep-disordered breathing. It is one of the companies listed in the top ASX 200.
RMD has reported a 30% increase in FY10 net profit to US$190.1 million, with revenue up 19% to US$1.1 billion.
RMD attributed the revenue growth to the market share gains in the Americas as well as the positive roll out of its new S9 Autoset and Elite flow generator products.
In addition to its result, RMD has announced a 2:1 stock split in the form of a 100% stock dividend to its shareholders.
Australian share price for RMD shares dropped 1.9% last Friday.